Annals of Indian Academy of Neurology
  Users Online: 3575 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
REVIEW: MANAGEMENT UPDATES
Year : 2009  |  Volume : 12  |  Issue : 4  |  Page : 273-282

Disease-modifying agents in multiple sclerosis


Department of Neurology, Stony Brook University Medical Center, Stony Brook, New York, USA

Correspondence Address:
P K Coyle
Department of Neurology, Stony Brook University Medical Center, Stony Brook, New York
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-2327.58280

Rights and Permissions

Since 1993, six disease-modifying therapies for multiple sclerosis (MS) have been proven to be of benefit in rigorous phase III clinical trials. Other agents are also available and are used to treat MS, but definitive data on their efficacy is lacking. Currently, disease-modifying therapy is used for relapsing forms of MS. This includes clinically isolated syndrome/first-attack high-risk patients, relapsing patients, secondary progressive patients who are still experiencing relapses, and progressive relapsing patients. The choice of agent depends upon drug factors (including affordability, availability, convenience, efficacy, and side effects), disease factors (including clinical and neuroimaging prognostic indicators), and patient factors (including comorbidities, lifestyle, and personal preference). This review will discuss the disease-modifying agents used currently in MS, as well as available alternative agents.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3576    
    Printed159    
    Emailed2    
    PDF Downloaded277    
    Comments [Add]    
    Cited by others 7    

Recommend this journal